US 10604771
Delivery methods and compositions for nuclease-mediated genome engineering
granted A61KA61K35/28
Quick answer
US patent 10604771 (Delivery methods and compositions for nuclease-mediated genome engineering) held by Sangamo Therapeutics, Inc. expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K35/28